ribavirin has been researched along with pleconaril in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 5 (35.71) | 2.80 |
| Authors | Studies |
|---|---|
| Atzori, EM; Biava, M; Collu, G; Delogu, I; Desideri, N; Droghini, P; Fioravanti, R; Ibba, C; Loddo, R; Sanna, G | 1 |
| Hou, Q; Jiang, JD; Li, L; Li, Y; Li, YH; Liu, YB; Ma, SG; Qu, J; Shi, YS; Yu, SS; Yuan, SP | 1 |
| Boido, V; Collu, G; Delogu, I; Giliberti, G; La Colla, P; Loddo, R; Novelli, F; Sparatore, A; Sparatore, F; Tasso, B; Tonelli, M | 1 |
| Chang, X; Chen, S; Chen, X; Du, C; Gu, Z; Guo, Q; Hao, F; He, H; Hu, G; Hu, J; Li, J; Li, P; Lin, F; Lin, T; Shen, L; Shi, X; Sun, Y; Tian, X; Wang, L; Wang, Z; Xiao, W; Xu, D; Yu, J; Zhang, X | 1 |
| Atzori, EM; Carta, A; Collu, G; Delogu, I; Desideri, N; Fioravanti, R; Loddo, R | 1 |
| Cen, S; Chen, J; Jiang, X; Jiang, Z; Jin, J; Li, J; Li, Y; Li, Z; Peng, Z; Quan, Y; Tan, J; Wang, Y | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Berggren, PO; Blixt, M; Holmberg, R; Juntti-Berggren, L; Klitz, W; Niklasson, B | 1 |
| Baek, SH; Choi, HJ; Kwon, DH; Lim, CH; Song, JH | 1 |
| Cao, Q; Deng, Y; Ding, C; Feng, D; Gu, B; Hu, W; Wang, J; Xie, F; Yao, K; Zhang, C; Zhang, G; Zhou, F | 1 |
| Day, CW; Evans, WJ; Nicolaou, KC; Smee, DF; Tarbet, EB | 1 |
| Honkimaa, A; Hyöty, H; Sioofy-Khojine, AB | 1 |
| Berggren, PO; Juntti-Berggren, L; Klitz, W; Lindquist, L; Niklasson, B | 1 |
| Barker, P; Dahl-Jørgensen, K; Hanssen, KF; Hessel, TW; Hyöty, H; Johannesen, J; Krogvold, L; Lindblom, N; Ludvigsson, J; Mynarek, IM; Mørk, FB; Ponzi, E; Roald, T; Westman, J | 1 |
1 trial(s) available for ribavirin and pleconaril
| Article | Year |
|---|---|
Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial.
Topics: Adolescent; Antiviral Agents; C-Peptide; Child; Diabetes Mellitus, Type 1; Double-Blind Method; Humans; Ribavirin | 2023 |
13 other study(ies) available for ribavirin and pleconaril
| Article | Year |
|---|---|
N-((1,3-Diphenyl-1H-pyrazol-4-yl)methyl)anilines: A novel class of anti-RSV agents.
Topics: Aniline Compounds; Antiviral Agents; Cell Line; Humans; Pyrazoles; Respiratory Syncytial Viruses; Virus Replication | 2015 |
Bioactive Sesquiterpenes and Lignans from the Fruits of Xanthium sibiricum.
Topics: Animals; Anti-Inflammatory Agents; Crystallography, X-Ray; Dogs; Drugs, Chinese Herbal; Fruit; Influenza A Virus, H1N1 Subtype; Inhibitory Concentration 50; Lignans; Macrophages; Madin Darby Canine Kidney Cells; Mice; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Sesquiterpenes; Vero Cells; Xanthium | 2015 |
Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5.
Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Cricetinae; DNA Viruses; Dogs; Enterovirus B, Human; Humans; RNA Viruses; Structure-Activity Relationship; Triazoles; Virus Replication | 2015 |
Discovery of Potent EV71 Capsid Inhibitors for Treatment of HFMD.
Topics: | 2017 |
Inhibitors of Yellow Fever Virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: Design, synthesis and antiviral evaluation.
Topics: Animals; Antiviral Agents; Cattle; Cell Line; Cell Survival; Cricetinae; Dose-Response Relationship, Drug; Drug Design; Haplorhini; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Structure-Activity Relationship; Virus Replication; Yellow fever virus | 2017 |
2-((4-Arylpiperazin-1-yl)methyl)benzonitrile Derivatives as Orally Available Inhibitors of Hepatitis C Virus with a Novel Mechanism of Action.
Topics: Administration, Oral; Animals; Antiviral Agents; Cell Line; Dogs; Drug Design; Drug Resistance, Viral; Female; Half-Life; Hepacivirus; Humans; Male; Mice; Mutation; Nitriles; Rats; Structure-Activity Relationship; Virus Replication | 2020 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Antiviral treatments reduce severity of diabetes in Ljungan virus-infected CD-1 mice and delay onset in diabetes-prone BB rats.
Topics: Animals; Antibodies, Viral; Antiviral Agents; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Humans; Immunologic Factors; Mice; Oxadiazoles; Oxazoles; Parechovirus; Picornaviridae Infections; Rats; Rats, Inbred BB; Ribavirin | 2009 |
Anti-human rhinovirus activity of raoulic acid from Raoulia australis.
Topics: Antiviral Agents; Asteraceae; Common Cold; Humans; Microbial Sensitivity Tests; Oxadiazoles; Oxazoles; Phytotherapy; Picornaviridae Infections; Plant Extracts; Rhinovirus; Ribavirin; Terpenes; Virus Internalization | 2010 |
In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection.
Topics: Animals; Animals, Newborn; Antiviral Agents; Cell Line, Tumor; Cell Survival; Child, Preschool; Disease Models, Animal; Enterovirus A, Human; Enterovirus Infections; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxadiazoles; Oxazoles; Ribavirin; Survival Analysis | 2012 |
Susceptibilities of enterovirus D68, enterovirus 71, and rhinovirus 87 strains to various antiviral compounds.
Topics: A549 Cells; Antimetabolites; Antiviral Agents; Benzimidazoles; Enterovirus A, Human; Enterovirus D, Human; Guanine; HeLa Cells; Humans; Oxadiazoles; Oxazoles; Oximes; Picornaviridae; Piperazines; Piperidines; Pyridazines; Rhabdomyosarcoma; Rhinovirus; Ribavirin; Sulfonamides | 2016 |
A preclinical assessment to repurpose drugs to target type 1 diabetes-associated type B coxsackieviruses.
Topics: A549 Cells; Amides; Antiviral Agents; Azithromycin; Benzimidazoles; Coxsackievirus Infections; Diabetes Mellitus, Type 1; Drug Repositioning; Enterovirus B, Human; Fluoxetine; Guanidine; Humans; Immunoglobulin G; Lovastatin; Oxadiazoles; Oxazoles; Oximes; Pyrazines; Ribavirin; Sulfonamides | 2020 |
Effectiveness of Antivirals in a Type 1 Diabetes Model and the Move Toward Human Trials.
Topics: Adult; Alkynes; Animals; Antiviral Agents; Benzoxazines; Cyclopropanes; Diabetes Mellitus, Type 1; Humans; Male; Oxadiazoles; Oxazoles; Proof of Concept Study; Rats; Ribavirin | 2020 |